Klinko Karya Imaji Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Klinko Karya Imaji Tbk. trades at Rp106 (market cap 126.83B, 217.2K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is the larger of the two by market cap, and Klinko Karya Imaji Tbk. is more actively traded (217.2K versus 96.7K). Which is the better fit depends on your goals.
| KLIN | OBAT | |
|---|---|---|
Market Cap | 126.83B | 167.37B |
Volume | 217.2K | 96.7K |
Lot | 2.17K | 967 |
Turnover | 21.79M | 23.82M |
Average Price | 100.34 | 246.34 |
Value | 21.79M | 23.82M |
Indicative Equilibrium Price | 106 | 248 |
Indicative Equilibrium Volume | 34 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Klinko Karya Imaji Tbk (the Company) was established on November 4, 2016 based on Notarial Deed No. 3 by Ribka Avie Alreta, S.H., M.Kn. The Company started its commercial operations in 2017.
Read more on KLIN →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →